DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of...
4 insider purchases on record · latest filing 2024-03-11.
Insiders have also filed 19 sale transactions at DBVT.